We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Image of Dr. Heather Kay Webb Hsu

Dr. Heather Kay Webb Hsu

Chief Scientific Officer, Inipharm

Heather Kay Webb Hsu is the Chief Scientific Officer for Inipharm, a startup pharmaceutical company focused on discovery of drugs targeting genetically-defined mechanisms for the treatment of chronic liver disease. She comes to this position with 23 years of pharmaceutical/biotech industry experience with research, nonclinical development and clinical pharmacology. She has built, participated in and led teams of skilled professionals that have brought multiple drugs from discovery through to clinical proof of concept. Including participating in regulatory filings and communication for drugs in clinical development through to approval. After completing her PhD at the University of Michigan, her drug development work includes programs including but not limited to oncology, inflammatory and cardiometabolic diseases at companies including Johnson and Johnson and Gilead Sciences as well as small companies.

Got a question for Dr. Heather Kay Webb Hsu?

Get in touch using the contact form linked here and we’ll get back to you shortly